BMRT® is used in various medical indications as described above. Nevertheless, it has generally been found that patients treated with BMRT® not only have a longer lifespan than the average population, but also generally feel better, stronger and healthier. This was also documented by means of a VAS analysis as well.

 

On a 20-year-base a total of 97 patients (11.9%) aged 70 years and more were treated for different

conditions.

​

Results: Of all 97 patients, 89 were still alive on the cut-off date of the study (August 2023). The

oldest patient is 97 years old. 4 patients who deceased were between 85 and 96 years old.

​

Conclusion:

General health condition – health improvement according to the patient's subjective perception

 

Total: 817 (100 % - all patients with various indications)

Pre-treatment average: VAS 1.4 points

Post treatment average: VAS 9.5 points

1 year post treatment average: VAS 9.2 points of maximum 10 points

​

In summary, it can be stated that longevity, health condition and patients’ personal perception of well-being improved significantly after BMRT® Ultra High Dosage Antibody Therapy in all indications described.